Hepatitis B virus

References

• Blumberg BS, Alter HJ, Visnich S. A “new” antigen in leukemia sera. JAMA 1965: 191(Feb 15): 541–6
   Google Scholar
• Tiollais P, Charnay P, Vyas GN. Biology of hepatitis B virus. Science 1981: 213(4506): 406–11
   PubMed Web of Science ®Google Scholar
• Dienstag JL. Non-A. non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983: 85(2): 439–62
   PubMed Web of Science ®Google Scholar
• Chan KH, Hargie MP, Decker RH, et al. Serodiagnosis of recent hepatitis B Infection by IgM class anti-HBc. Hepatology 1983: 3(2): 142–9
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Dusheiko GM, Seeff LB, et al. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981: 94(6): 744–8
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Alter HJ. Chronic viral hepatitis. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral hepatitis and liver disease. New York: Grune & Stratton, 1984: 97–113
   Google Scholar
• Hoofnagle JH, Dosheiko GM, Schafer DF, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982: 96(4): 447–9
   PubMed Web of Science ®Google Scholar
• Davis GL, Hoofnagle JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984: 86(2): 230–5
   PubMed Web of Science ®Google Scholar
• Anderson KE, Son SC, Berg HS, et al. Liver function and histology in asymptomatic Chinese military personnel with hepatitis B antigenemia. Am J Dig Dis 1974: 19(8): 693–703
   PubMedGoogle Scholar
• Shrago SS, Auslander MO, Gitnick GL. Hepatic pathologic condition in asymptomatic Australian antigen carriers: a light microscopical study of 26 cases and a review of the literature. Arch Pathol Lab Med 1977: 101(92): 648–51
   PubMed Web of Science ®Google Scholar
• Weissberg JL Andres LL, Smith CL et al. Survival in chronic hepatitis B: an analysis of 379 patients. Ann Intern Med 1984: 101 (5): 613–6
   PubMed Web of Science ®Google Scholar
• Bréchot C, Degos F, Lugassy C. et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985: 312(5): 270–6
   PubMed Web of Science ®Google Scholar
• Beasley RP, Hwang LT, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 1981: 2(8256): 1129–33
   PubMed Web of Science ®Google Scholar
• Shafritz DA, Shouval D, Sherman HL et al. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma: studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med 1981: 305(18): 1067–73
   PubMed Web of Science ®Google Scholar
• Bréchet C, Nalpas B, Couroucé AM, et al. Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med 1982: 306(23): 1384–7
   PubMed Web of Science ®Google Scholar
• Lam KC, Lai CL, Trepo C, et al. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 1981: 304(7): 380–6
   PubMed Web of Science ®Google Scholar
• Bassendine MF, Chadwick RG, Salmeron J, et al. Adenine arabinoslde therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology 1981: 80(5 Pt 1): 1016–22
   PubMed Web of Science ®Google Scholar
• Rizzetto M. The delta agent. Hepatology 1983: 3(5): 729–37
   PubMed Web of Science ®Google Scholar
• Hadler SC, de Monzon M, Ponzetto A, et al. Delta virus infection and severe hepatitis: an epidemic in the Yucpa Indians of Venezuela. Ann Intern Med 1984: 100(3): 339–44
   PubMed Web of Science ®Google Scholar
• Govindarajan S, Chin KP, Redeker AG, et al. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984: 86(6): 1417–20
   PubMed Web of Science ®Google Scholar
• Smedile A. Dentico P. Zanetti A, et al. Infection with the delta agent in chronic HBsAg earners. Gastroenterology 1981: 81(6): 992–7
   PubMed Web of Science ®Google Scholar
• De Cock KM, Govindarajan S, Redeker AG. Fulminant delta hepatitis in chronic hepatitis B Infection. JAMA 1984: 252(19): 2746–8
   PubMed Web of Science ®Google Scholar
• Rizzetto M, Verme G, Recchia S, et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen: an active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983: 98(4): 437–41
   PubMed Web of Science ®Google Scholar
• Kanel GC, Govindarajan S, Peters RL. Chronic delta infection and liver biopsy changes in chronic active hepatitis B. Ann Intern Med 1984: 101(1): 51–4
   PubMed Web of Science ®Google Scholar
• Koff RS, Slavin Mil Connelly JD, et al. Contagiousness of acute hepatitis B: secondary attack rates in household contacts. Gastroenterology 1977: 72(2): 297–300
   PubMed Web of Science ®Google Scholar
• Dienstag JL, Werner BG, Polk BF, et al. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med 1984: 101(1): 34–40
   PubMed Web of Science ®Google Scholar
• Szmuness W, Stevens CE, Zang EA, et al. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report Hepatology 1981: 1(5): 377–85
   Google Scholar
• Mulley AG, Silverstein MD, Dienstag JL. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med 1982: 307(11): 644–52
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Suboptimal response to hepatitis B vaccine given by injection Into the buttock. MMWR 1985: 34(8): 105–8
   PubMedGoogle Scholar
• Centers for Disease Control. Postexposure prophylaxis of hepatitis B: recommendations of the Immunization Practices Advisory Committee. Ann Intern Med 1984: 101(3): 351–4
   PubMed Web of Science ®Google Scholar
• Szmuness W, Stevens CE, Oleszko WR, et al. Passive-active immunisation against hepatitis B: Immunogenicity studies in adult Americans. Lancet 1981: 1(8220 Pt 1): 575–7
   PubMed Web of Science ®Google Scholar
• Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus Infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983: 2(8359): 1099–102
   PubMed Web of Science ®Google Scholar
• Jilg W, Lorbeer B, Schmidt M, et al. Clinical evaluation of a recombinant hepatitis B vaccine. Lancet 1984: 2(8413): 1174–5
   PubMed Web of Science ®Google Scholar
• Barin F, Goudeau A, Denis F, et al. Immune response In neonates to hepatitis B vaccine. Lancet 1982: 1(8266): 251–3
   PubMed Web of Science ®Google Scholar
• Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology 1983: 3(2): 135–41
   PubMed Web of Science ®Google Scholar